Skip to main content
Premium Trial:

Request an Annual Quote

Dx Focus: BioFire Gets CE Mark for FilmArray Blood Culture

Premium

BioFire Diagnostics said this week that it has received the CE IVD mark for its FilmArray Blood Culture Identification Panel.

The BCID Panel tests positive blood cultures and can identify more than 100 blood pathogens known to cause sepsis. The assay requires two minutes of hands-on time, and can identify pathogens in nine out of 10 positive blood cultures in about one hour.

BioFire said that it is the only test that provides results for gram-positive bacteria, gram-negative bacteria, and bloodstream infection-causing yeast. In addition, the BCID Panel detects four antimicrobial resistance genes (mecA, vanA, vanB and blaKPC) known to confer resistance to methicillin/oxacillin, vancomycin, and carbapenems. Identification of these resistance markers will provide physicians with information that can help to guide more timely selection of appropriate antimicrobial treatments, the company said.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.